Publications by authors named "G Mura"

Article Synopsis
  • A study investigated the prevalence and factors linked to CNS-active polypharmacy in older adults (60+) in Buenos Aires, finding that 7.1% of patients were using three or more CNS-active medications.
  • The research included 63,857 patients, revealing that common combinations of medications involved antidepressants, antipsychotics, and benzodiazepines, particularly in those with mental health disorders.
  • Conditions like frontotemporal dementia and schizophrenia significantly increased the odds of polypharmacy, highlighting the need for strategies to manage medication use in older populations.
View Article and Find Full Text PDF

Pilates-based programs can help pregnant women deal with the physical and psychological burden derived by major changes in their body. This study was designed to primarily test, in pregnant women, the dose-response and health effects of both pre-partum and post-partum, online Pilates-based program on weight control, low back pain (LBP) severity, sleep disturbances, mood and depression levels. A total of 136 pregnant women were screened for eligibility (low-risk pregnancy; aged 18-45 years; single pregnancy; 20-28-week gestational age, normal BMI).

View Article and Find Full Text PDF

Background: Many gastric cancer patients in Western countries are diagnosed as metastatic with a median overall survival of less than twelve months using standard chemotherapy. Innovative treatments, like targeted therapy or immunotherapy, have recently proved to ameliorate prognosis, but a general agreement on managing oligometastatic disease has yet to be achieved. An international multi-disciplinary workshop was held in Bertinoro, Italy, in November 2022 to verify whether achieving a consensus on at least some topics was possible.

View Article and Find Full Text PDF

Hormone receptor (HR)-positive/HER2-positive breast cancer represents a distinct subtype expressing estrogen and progesterone receptors with an overexpression of HER2. Approximately 14% of female breast cancer cases are HER2-positive, with the majority being HR-positive. These tumors show a cross-talk between the hormonal and HER2 pathways; the interaction has implications for the treatment options for the disease.

View Article and Find Full Text PDF